Benign prostatic hyperplasia: Cost and effectiveness of three alternative surgical treatment methods used in a Turkish hospital

被引:1
|
作者
Agirbas I. [1 ]
Tatar M. [2 ]
Kisa A. [3 ]
机构
[1] Department of Health Administration, School of Health Education, Ankara University, Kecioren, Ankara
[2] School of Health Administration, Hacettepe University, Ankara
[3] Department of Health Administration, Baskent University, School of Health Sciences, 06530, Ankara
关键词
Benign prostatic hyperplasia; Cost effectiveness; Laser prostatectomy; Open prostatectomy; TURP;
D O I
10.1007/s10916-005-6105-5
中图分类号
学科分类号
摘要
The purpose of this study was to compare three alternative surgical therapies for Benign prostatic hyperplasia (BPH) in terms of their cost and effectiveness in a general hospital setting in Turkey. BPH is an important potential burden on health care resources in developing countries like Turkey, not only because of the increasing incidence of the disease, but also because of the differences in cost and effectiveness that exist among the various available treatment technologies. In this study, three alternative surgical treatments for BPH, namely open prostatectomy, transurethral resection of the prostate (TURP), and laser prostatectomy were compared in terms of their cost and effectiveness. Effectiveness was measured through the use of the International Prostate Symptom Score (IPSS) before the operation and at 3 months after. Laser prostatectomy was found to be the most costly and least effective way of treating BPH. This conclusion was valid both in terms of cost per prostate symptom score and cost per improvement of quality of life index. This study shows how a rough estimate can be made of the potential burdens that alternative treatment methods would impose on a country's health budget. © 2005 Springer Science+Business Media, Inc.
引用
收藏
页码:487 / 492
页数:5
相关论文
共 50 条
  • [41] ECONOMIC EVALUATION OF MEDICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH) IN THE SPECIALISED CARE SETTING IN SPAIN. APPLICATION TO THE COST-EFFECTIVENESS OF TWO DRUGS FREQUENTLY USED IN ITS TREATMENT
    Carballido, J.
    Ruiz-Cerda, J. L.
    Unda, M.
    Baena, V
    Campoy, P.
    Manasanch, J.
    Slof, J.
    ACTAS UROLOGICAS ESPANOLAS, 2008, 32 (09): : 916 - 925
  • [42] The evolution of photoselective vaporization prostatectomy (PVP): advancing the surgical treatment of benign prostatic hyperplasia
    Richard Lee
    Ricardo R. Gonzalez
    Alexis E. Te
    World Journal of Urology, 2006, 24 : 405 - 409
  • [43] PATIENT RECRUITMENT TO AND COST OF A PROSPECTIVE TRIAL OF MEDICAL-TREATMENT FOR BENIGN PROSTATIC HYPERPLASIA
    ERI, LM
    TVETER, KJ
    EUROPEAN UROLOGY, 1992, 22 (01) : 9 - 13
  • [44] Long-term cost analysis of treatment options for benign prostatic hyperplasia in Norway
    Johansen, Truls E. Bjerklund
    Istad, Jan Anders
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2007, 41 (02): : 124 - 131
  • [45] Drug treatment of benign prostatic hyperplasia and hospital admission for BPH-related surgery
    Souverein, PC
    Erkens, JA
    de la Rosette, JJMCH
    Leufkens, HGM
    Herings, RMC
    EUROPEAN UROLOGY, 2003, 43 (05) : 528 - 534
  • [46] Is Early Surgical Treatment for Benign Prostatic Hyperplasia Preferable to Prolonged Medical Therapy: Pros and Cons
    Fogaing, Cora
    Alsulihem, Ali
    Campeau, Lysanne
    Corcos, Jacques
    MEDICINA-LITHUANIA, 2021, 57 (04):
  • [47] Cost-effectiveness of alternative methods of surgical repair of inguinal hernia
    Vale, L
    Grant, A
    McCormack, K
    Scott, NW
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2004, 20 (02) : 192 - 200
  • [48] Should all specimens taken during surgical treatment of patients with benign prostatic hyperplasia be assessed by a pathologist?
    Skrzypczyk, Michal Andrzej
    Dobruch, Jakub
    Nyk, Lukasz
    Szostek, Przemyslaw
    Szemplinski, Stanislaw
    Borowka, Andrzej
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2014, 67 (03) : 227 - 232
  • [49] Is Race Associated with the Surgical Treatment for Benign Prostatic Hyperplasia? An Analysis of 30,000 Medicare Lives
    Gopal L. Narang
    Sirikan Rojanasarot
    Ben Cutone
    Mitchell R. Humphreys
    Journal of Racial and Ethnic Health Disparities, 2024, 11 : 528 - 534
  • [50] Is Race Associated with the Surgical Treatment for Benign Prostatic Hyperplasia? An Analysis of 30,000 Medicare Lives
    Narang, Gopal L. L.
    Rojanasarot, Sirikan
    Cutone, Ben
    Humphreys, Mitchell R. R.
    JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES, 2024, 11 (01) : 528 - 534